APSARD 2021 Poster References

References

Aasen, I. E., Øgrim, G., Kropotov, J., & Brunner, J. F. (2018). Methylphenidate selectively modulates one sub-component of the no-go P3 in pediatric ADHD medication responders. Biological Psychology, 134, 30-38. doi: 10.1016/j.biopsycho.2018.02.011

Broyd, S. J., Johnstone, S. J., Barry, R. J., Clarke, A. R., McCarthy, R., Selikowitz, M., & Lawrence, C. A. (2005). The effect of methylphenidate on response inhibition and the event-related potential of children with attention deficit/hyperactivity disorder. International Journal of Psychophysiology, 58, 47-58. doi: 10.1016/j.ijpsycho.2005.03.008

Burcu, M., Zito, J. M., Metcalfe, L., Underwood, H., & Safer, D. J. (2016). Trends in stimulant medication use in commercially insured youths and adults, 2010-2014. JAMA Psychiatry, 73, 992-993. doi: 10.1001/jamapsychiatry.2016.1182

Coons, H. W., Klorman, R., & Borgstedt, A. D. (1987). Effects of methylphenidate on adolescents with a childhood history of attention deficit disorder: II. Information processing. Journal of the American Academy of Child & Adolescent Psychiatry, 26, 368-374. doi: 10.1097/00004583-198705000-00016

Cortese, S., Adamo, N., Del Giovane, C., Mohr-Jensen, C., Hayes, A. J., Carucci, S., Atkinson, L., Tessari, L., Banaschewski, T., Coghill, C., Hollis, C., Simonoff, E., Zuddas, A., Barbui, C., Purgato, M., Steinhausen, H., Shokraneh, F., Xia, J., & Cipriani, A. (2018). Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis. The Lancet Psychiatry5, 727-738. doi: 10.1016/S2215-0366(18)30269-4

Dolu, N., Altınkaynak, M., Güven, A., Özmen, S., Demirci, E., İzzetoğlu, M., & Pektaş, F. (2019). Effects of methylphenidate treatment in children with ADHD: a multimodal EEG/fNIRS approach. Psychiatry and Clinical Psychopharmacology, 29(3), 285-292. doi: 10.1080/24750573.2018.1542779

Fitzpatrick, P. A., Klorman, R., Brumaghim, J. T., & Borgstedt, A. D. (1992). Effects of sustained-release and standard preparations of methylphenidate on attention deficit disorder. Journal of the American Academy of Child & Adolescent Psychiatry, 31, 226-234. doi: 10.1097/00004583-199203000-00008

Frank, Y. (1993). Visual event related potentials after methylphenidate and sodium valproate in children with attention deficit hyperactivity disorder. Clinical Electroencephalography, 24, 19-24. doi 10.1177/155005949302400106

Hermens, D. F., Williams, L. M., Clarke, S., Kohn, M., Cooper, N., & Gordon, E. (2005). Responses to methylphenidate in adolescent AD/HD: evidence from concurrently recorded autonomic (EDA) and central (EEG and ERP) measures. International Journal of Psychophysiology, 58, 21-33. doi: 10.1016/j.ijpsycho.2005.03.006

Janssen, T. W. P., Bink, M., Geladé, K., van Mourik, R., Maras, A., & Oosterlaan, J. (2016). A randomized controlled trial investigating the effects of neurofeedback, methylphenidate, and physical activity on event-related potentials in children with attention-deficit/hyperactivity disorder. Journal of Child and Adolescent Psychopharmacology, 26, 344-353. doi: 10.1089/cap.2015.0144

Jonkman, L. M., Kemner, C., Verbaten, M., Van Engeland, H., Kenemans, J., Camfferman, G., et al. (1999). Perceptual and response interference in children with attention‐deficit hyperactivity disorder, and the effects of methylphenidate. Psychophysiology, 36, 419-429.

Jonkman, L. M., Kemner, C., Verbaten, M. N., Koelega, H. S., Camfferman, G., vd Gaag, R.-J., et al. (1997). Event-related potentials and performance of attention-deficit hyperactivity disorder: children and normal controls in auditory and visual selective attention tasks. Biological Psychiatry, 41, 595-611. doi: 10.1016/S0006-3223(96)00073-X

Keage, H. A., Clark, C. R., Hermens, D. F., Williams, L. M., Kohn, M. R., Clarke, S., et al. (2008). ERP indices of working memory updating in AD/HD: differential aspects of development, subtype, and medication. Journal of Clinical Neurophysiology, 25, 32-41. doi: 10.1097/WNP.0b013e318163ccc0

Klorman, R., Brumaghim, J. T., Fitzpatrick, P. A., & Borgstedt, A. D. (1990). Clinical effects of a controlled trial of methylphenidate on adolescents with attention deficit disorder. Journal of the American Academy of Child & Adolescent Psychiatry29(5), 702-709. doi: 10.1097/00004583-199009000-00005

Klorman, R., Brumaghim, J. T., Fitzpatrick, P. A., & Borgstedt, A. D. (1992). Methylphenidate reduces abnormalities of stimulus classification in adolescents with attention deficit disorder. Journal of Abnormal Psychology, 101, 130-138. doi: 10.1037/0021-843X.101.1.130

Klorman, R., Brumaghim, J. T., Fitzpatrick, P. A., & Borgstedt, A. D. (1994). Clinical and cognitive effects of methylphenidate on children with attention deficit disorder as a function of aggression/oppositionality and age. Journal of Abnormal Psychology, 103, 206-221. doi: 10.1037/0021-843X.103.2.206

Klorman, R., Brumaghim, J. T., Salzman, L. F., Strauss, J., Borgstedt, A. D., McBride, M. C., & Loeb, S. (1988). Effects of methylphenidate on attention-deficit hyperactivity disorder with and without aggressive/noncompliant features. Journal of Abnormal Psychology, 97, 413-422. doi: 10.1037/0021-843X.97.4.413

Klorman, R., Salzman, L. F., Bauer, L. O., Coons, H. W., Borgstedt, A. D., & Halpern, W. I. (1983). Effects of two doses of methylphenidate on cross-situational and borderline hyperactive children’s evoked potentials. Electroencephalography and Clinical Neurophysiology56, 169-185. doi: 10.1016/0013-4694(83)90071-8

Konopka, L. M., & Zimmerman, E. M. (2014). Neurofeedback and Psychopharmacology: Designing Effective Treatment Based on Cognitive and EEG Effects of Medications. In Clinical Neurotherapy (pp. 55-84): Elsevier. doi: 10.1016/B978-0-12-396988-0.00003-9

Lawrence, C. A., Barry, R. J., Clarke, A. R., Johnstone, S. J., McCarthy, R., Selikowitz, M., & Broyd, S. J. (2005). Methylphenidate effects in attention deficit/hyperactivity disorder: electrodermal and ERP measures during a continuous performance task. Psychopharmacology, 183, 81-91. doi: 10.1007/s00213-005-0144-y

Lubar, J. F., Swartwood, M., Swartwood, J., & Timmermann, D. (1995). Quantitative EEG and auditory event-related potentials in the evaluation of attention-deficit/hyperactivity disorder: Effects of methylphenidate and implications for neurofeedback training. Journal of Psychoeducational Assessment, 34, 143-160.

Michael, R. L., Klorman, R., Salzman, L. F., Borgstedt, A. D., & Dainer, K. B. (1981). Normalizing effects of methylphenidate on hyperactive children’s vigilance performance and evoked potentials. Psychophysiology, 18, 665-677. doi: 10.1111/j.1469-8986.1981.tb01841.x

Ogrim, G., Aasen, I. E., & Brunner, J. F. (2016). Single-dose effects on the P3no-go ERP component predict clinical response to stimulants in pediatric ADHD. Clinical Neurophysiology127, 3277-3287. doi: 10.1016/j.clinph.2016.07.011

Ogrim, G., & Hestad, K. A. (2013). Effects of neurofeedback versus stimulant medication in attention-deficit/hyperactivity disorder: a randomized pilot study. Journal of Child and Adolescent Psychopharmacology23, 448-457. doi: 10.1089/cap.2012.0090

Ogrim, G., Kropotov, J., Brunner, J. F., Candrian, G., Sandvik, L., & Hestad, K. A. (2014). Predicting the clinical outcome of stimulant medication in pediatric attention-deficit/hyperactivity disorder: data from quantitative electroencephalography, event-related potentials, and a go/no-go test. Neuropsychiatric Disease and Treatment, 10, 231-242. doi: 10.2147/NDT.S56600

Ogrim, G., & Kropotov, J. D. (2019). Predicting clinical gains and side effects of stimulant medication in pediatric attention-deficit/hyperactivity disorder by combining measures from qEEG and ERPs in a Cued GO/NOGO task. Clinical EEG & Neuroscience, 50, 34-43. doi: 10.1177/1550059418782328

Okazaki, S., Maekawa, H., Ozaki, H., & Futakami, S. (2002, April). Topographic changes of ERP during a CPT-AX task at pre-and post-medication of methylphenidate in children with ADHD. In International Congress Series (Vol. 1232, pp. 705-710). Elsevier. doi: 10.1016/S0531-5131(01)00814-7

Ozdag, M., Yorbik, O., Ulas, U., Hamamcioglu, K., & Vural, O. (2004). Effect of methylphenidate on auditory event related potential in boys with attention deficit hyperactivity disorder. International Journal of Pediatric Otorhinolaryngology, 68, 1267-1272. doi: 10.1016/j.ijporl.2004.04.023

Paul-Jordanov, I., Bechtold, M., & Gawrilow, C. (2010). Methylphenidate and if-then plans are comparable in modulating the P300 and increasing response inhibition in children with ADHD.  ADHD Attention Deficit and Hyperactivity Disorders, 2, 115-126. doi: 10.1007/s12402-010-0028-9

Pliszka, S. R., Liotti, M., Bailey, B. Y., Perez III, R., Glahn, D., & Semrud-Clikeman, M. (2007). Electrophysiological effects of stimulant treatment on inhibitory control in children with attention-deficit/hyperactivity disorder. Journal of Child & Adolescent Psychopharmacology, 17, 356-366. doi: 10.1089/cap.2006.0081

Prichep, L. S., Sutton, S., & Hakerem, G. (1976). Evoked potentials in hyperkinetic and normal children under certainty and uncertainty: A placebo and methylphenidate study. Psychophysiology, 13, 419-428. doi: 10.1111/j.1469-8986.1976.tb00855.x

Rubinson, M., Horowitz, I., Naim-Feil, J., Gothelf, D., Levit-Binnun, N., & Moses, E. (2019). Effects of methylphenidate on the ERP amplitude in youth with ADHD: A double-blind placebo-controlled cross-over EEG study. PloS one, 14, e0217383. doi: 10.1371/journal.pone.0217383

Sangal, J. M., & Sangal, R. B. (2004). Attention-deficit/hyperactivity disorder: cognitive evoked potential (P300) topography predicts treatment response to methylphenidate. Clinical Neurophysiology, 115, 188-193. doi: 10.1016/j.clinph.2003.08.023

Sangal, R. B., & Sangal, J. M. (2006). Attention-deficit/hyperactivity disorder: use of cognitive evoked potential (P300) to predict treatment response. Clinical Neurophysiology, 117, 1996-2006. doi: 10.1016/j.clinph.2006.06.004

Satterfield, J. H., Cantwell, D. P., Lesser, L. I., & Podosin, R. L. (1972). Physiological studies of the hyperkinetic child: American Journal of Psychiatry, 128, 1418-1424.

Seifert, J., Scheuerpflug, P., Zillessen, K.-E., Fallgatter, A., & Warnke, A. (2003). Electrophysiological investigation of the effectiveness of methylphenidate in children with and without ADHD. Journal of Neural Transmission, 110, 821-829. doi: 10.1007/s00702-003-0818-8

Smithee, J. A. F., Klorman, R., Brumaghim, J. T., & Borgstedt, A. D. (1998). Methylphenidate does not modify the impact of response frequency or stimulus sequence on performance and event-related potentials of children with attention deficit hyperactivity disorder. Journal of Abnormal Child Psychology, 26, 233-245. doi: 10.1023/A:1022698232481

Sunohara, G. A., Malone, M. A., Rovet, J., Humphries, T., Roberts, W., & Taylor, M. J. (1999). Effect of methylphenidate on attention in children with attention deficit hyperactivity disorder (ADHD): ERP evidence. Neuropsychopharmacology, 21, 218-228. doi: 10.1016/S0893-133X(99)00023-8

Taylor, M., Voros, J., Logan, W., & Malone, M. (1993). Changes in event-related potentials with stimulant medication in children with attention deficit hyperactivity disorder. Biological Psychology, 36, 139-156. doi: 10.1016/0301-0511(93)90015-Z

Verbaten, M., Overtoom, C., Koelega, H., Swaab-Barneveld, H., Van der Gaag, R., Buitelaar, J., & Van Engeland, H. (1994). Methylphenidate influences on both early and late ERP waves of ADHD children in a continuous performance test. Journal of Abnormal Child Psychology, 22, 561-578. doi: 10.1007/BF02168938

Williams, L. M., Hermens, D. F., Palmer, D., Kohn, M., Clarke, S., Keage, H., et al. (2008). Misinterpreting emotional expressions in attention-deficit/hyperactivity disorder: evidence for a neural marker and stimulant effects. Biological Psychiatry, 63, 917-926. doi: 10.1016/j.biopsych.2007.11.022

Winsberg, B. G., Javitt, D. C., & Shanahan, G. (1997). Electrophysiological indices of information processing in methylphenidate responders. Biological Psychiatry, 42, 434-445. doi: 10.1016/S0006-3223(96)00429-5

Zillessen, K., Scheuerpflug, P., Fallgatter, A., Strik, W., & Warnke, A. (2001). Changes of the brain electrical fields during the continuous performance test in attention-deficit hyperactivity disorder-boys depending on methylphenidate medication. Clinical Neurophysiology, 112, 1166-1173. doi: 10.1016/S1388-2457(01)00535-1